Psychotropic drugs misused in France

9 July 2006

A study commissioned by France's parliamentary office for the evaluation of health policies (OPEPS) has found that the French are the heaviest users of psychotropic drugs in Europe, confirming data over the past 10 years. Researchers from the Inserm government research department and the University of Bordeaux estimate that health insurance reimbursements of psychotropics has risen from 300.0 million euros ($376.5 million) in 1980 to 1.0 billion euros in 2004.

One in four adults uses a psychotropic at least once a year

"Mental problems" represent the forth largest item of drug expenditure in France, accounting for the second place in terms of prescriptions filled, at 122 million packs sold in 2005. According to these findings, one adult in four uses psychotropic products at least once per year.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight